These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26973199)

  • 1. Factors influencing the concordance of histological subtype diagnosis from biopsy and resected specimens of lung adenocarcinoma.
    Matsuzawa R; Kirita K; Kuwata T; Umemura S; Matsumoto S; Fujii S; Yoh K; Kojima M; Niho S; Ohmatsu H; Ochiai A; Tsuboi M; Goto K; Ishii G
    Lung Cancer; 2016 Apr; 94():1-6. PubMed ID: 26973199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytopathology of pulmonary adenocarcinoma with a single histological pattern using the proposed International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) classification.
    Rodriguez EF; Dacic S; Pantanowitz L; Khalbuss WE; Monaco SE
    Cancer Cytopathol; 2015 May; 123(5):306-17. PubMed ID: 25788465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonpredominant lepidic pattern correlates with better outcome in invasive lung adenocarcinoma.
    Mäkinen JM; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Lappi-Blanco E; Kaarteenaho R
    Lung Cancer; 2015 Dec; 90(3):568-74. PubMed ID: 26506915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations.
    Tsuta K; Kawago M; Inoue E; Yoshida A; Takahashi F; Sakurai H; Watanabe SI; Takeuchi M; Furuta K; Asamura H; Tsuda H
    Lung Cancer; 2013 Sep; 81(3):371-376. PubMed ID: 23891509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma.
    Murakami S; Ito H; Tsubokawa N; Mimae T; Sasada S; Yoshiya T; Miyata Y; Yokose T; Okada M; Nakayama H
    Lung Cancer; 2015 Nov; 90(2):199-204. PubMed ID: 26341957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between EGFR Mutations and Pathological Classification and 
Specimen of Lung Adenocarcinoma].
    Kang L; Zheng J; Zhu X
    Zhongguo Fei Ai Za Zhi; 2017 Jun; 20(6):382-388. PubMed ID: 28641695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Close association of IASLC/ATS/ERS lung adenocarcinoma subtypes with glucose-uptake in positron emission tomography.
    Nakamura H; Saji H; Shinmyo T; Tagaya R; Kurimoto N; Koizumi H; Takagi M
    Lung Cancer; 2015 Jan; 87(1):28-33. PubMed ID: 25481488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the histologic predominance of pathological stage IA lung adenocarcinoma influence the extent of resection?
    Ito H; Nakayama H; Murakami S; Yokose T; Katayama K; Miyata Y; Okada M
    Gen Thorac Cardiovasc Surg; 2017 Sep; 65(9):512-518. PubMed ID: 28593420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT-Guided Core Biopsy for Peripheral Sub-solid Pulmonary Nodules to Predict Predominant Histological and Aggressive Subtypes of Lung Adenocarcinoma.
    Tsai PC; Yeh YC; Hsu PK; Chen CK; Chou TY; Wu YC
    Ann Surg Oncol; 2020 Oct; 27(11):4405-4412. PubMed ID: 32361797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of the IASLC/ATS/ERS histological subtyping of stage I lung adenocarcinoma on intraoperative frozen sections.
    Trejo Bittar HE; Incharoen P; Althouse AD; Dacic S
    Mod Pathol; 2015 Aug; 28(8):1058-63. PubMed ID: 26022456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second predominant subtype predicts outcomes of intermediate-malignant invasive lung adenocarcinoma†.
    Ito M; Miyata Y; Yoshiya T; Tsutani Y; Mimura T; Murakami S; Ito H; Nakayama H; Okada M
    Eur J Cardiothorac Surg; 2017 Feb; 51(2):218-222. PubMed ID: 28186287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma.
    Hung JJ; Jeng WJ; Chou TY; Hsu WH; Wu KJ; Huang BS; Wu YC
    Ann Surg; 2013 Dec; 258(6):1079-86. PubMed ID: 23532112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of small biopsy and cytology specimens: Subtyping of pulmonary adenocarcinoma.
    Ma C; Zhang L
    Cytojournal; 2023; 20():5. PubMed ID: 36895259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excellent prognosis of lepidic-predominant lung adenocarcinoma: low incidence of lymphatic vessel invasion as a key factor.
    Araki K; Kidokoro Y; Hosoya K; Wakahara M; Matsuoka Y; Takagi Y; Haruki T; Miwa K; Taniguchi Y; Horie S; Nakamura H
    Anticancer Res; 2014 Jun; 34(6):3153-6. PubMed ID: 24922687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know.
    Eguchi T; Kadota K; Park BJ; Travis WD; Jones DR; Adusumilli PS
    Semin Thorac Cardiovasc Surg; 2014; 26(3):210-22. PubMed ID: 25527015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of EGFR mutation and histological subtype according to the IASLC/ATS/ERS classification of lung adenocarcinoma.
    Chen Z; Liu X; Zhao J; Yang H; Teng X
    Int J Clin Exp Pathol; 2014; 7(11):8039-45. PubMed ID: 25550848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patients.
    Russell PA; Barnett SA; Walkiewicz M; Wainer Z; Conron M; Wright GM; Gooi J; Knight S; Wynne R; Liew D; John T
    J Thorac Oncol; 2013 Apr; 8(4):461-8. PubMed ID: 23486266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inaccuracy of lung adenocarcinoma subtyping using preoperative biopsy specimens.
    Huang KY; Ko PZ; Yao CW; Hsu CN; Fang HY; Tu CY; Chen HJ
    J Thorac Cardiovasc Surg; 2017 Jul; 154(1):332-339.e1. PubMed ID: 28366548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extraction of radiomic values from lung adenocarcinoma with near-pure subtypes in the International Association for the Study of Lung Cancer/the American Thoracic Society/the European Respiratory Society (IASLC/ATS/ERS) classification.
    Yang SM; Chen LW; Wang HJ; Chen LR; Lor KL; Chen YC; Lin MW; Hsieh MS; Chen JS; Chang YC; Chen CM
    Lung Cancer; 2018 May; 119():56-63. PubMed ID: 29656753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Added prognostic value of CT characteristics and IASLC/ATS/ERS histologic subtype in surgically resected lung adenocarcinomas.
    Suh YJ; Lee HJ; Kim YT; Kang CH; Park IK; Jeon YK; Chung DH
    Lung Cancer; 2018 Jun; 120():130-136. PubMed ID: 29748007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.